These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 9364673

  • 21. Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid.
    Gupta RK, Chang AC, Griffin P, Rivera R, Guo YY, Siber GR.
    Vaccine; 1997; 15(6-7):672-8. PubMed ID: 9178469
    [Abstract] [Full Text] [Related]

  • 22. Comparison of in vitro and in vivo methods to study stability of PLGA microencapsulated tetanus toxoid vaccines.
    Sasiak AB, Bolgiano B, Crane DT, Hockley DJ, Corbel MJ, Sesardic D.
    Vaccine; 2000 Nov 22; 19(7-8):694-705. PubMed ID: 11115690
    [Abstract] [Full Text] [Related]

  • 23. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs.
    Johansen P, Tamber H, Merkle HP, Gander B.
    Eur J Pharm Biopharm; 1999 May 22; 47(3):193-201. PubMed ID: 10382103
    [Abstract] [Full Text] [Related]

  • 24. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.
    Eldridge JH, Staas JK, Meulbroek JA, Tice TR, Gilley RM.
    Infect Immun; 1991 Sep 22; 59(9):2978-86. PubMed ID: 1879922
    [Abstract] [Full Text] [Related]

  • 25. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
    Shi L, Caulfield MJ, Chern RT, Wilson RA, Sanyal G, Volkin DB.
    J Pharm Sci; 2002 Apr 22; 91(4):1019-35. PubMed ID: 11948541
    [Abstract] [Full Text] [Related]

  • 26. Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern.
    Johansen P, Corradin G, Merkle HP, Gander B.
    J Control Release; 1998 Dec 04; 56(1-3):209-17. PubMed ID: 9801444
    [Abstract] [Full Text] [Related]

  • 27. Correlation between in vitro release and in vivo immune response from biodegradable polymer particles entrapping tetanus toxoid.
    Raghuvanshi RS, Singh O, Panda AK.
    Drug Deliv; 2002 Dec 04; 9(2):113-20. PubMed ID: 12055039
    [Abstract] [Full Text] [Related]

  • 28. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells.
    Walter E, Dreher D, Kok M, Thiele L, Kiama SG, Gehr P, Merkle HP.
    J Control Release; 2001 Sep 11; 76(1-2):149-68. PubMed ID: 11532321
    [Abstract] [Full Text] [Related]

  • 29. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres.
    Igartua M, Hernández RM, Esquisabel A, Gascón AR, Calvo MB, Pedraz JL.
    J Control Release; 1998 Dec 04; 56(1-3):63-73. PubMed ID: 9801430
    [Abstract] [Full Text] [Related]

  • 30. Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres.
    Allaoui-Attarki K, Fattal E, Pecquet S, Trollé S, Chachaty E, Couvreur P, Andremont A.
    Vaccine; 1998 Apr 04; 16(7):685-91. PubMed ID: 9562687
    [Abstract] [Full Text] [Related]

  • 31. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
    Herrero-Vanrell R, Ramirez L, Fernandez-Carballido A, Refojo MF.
    Pharm Res; 2000 Oct 04; 17(10):1323-8. PubMed ID: 11145241
    [Abstract] [Full Text] [Related]

  • 32. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D, Molavi O, Lutsiak ME, Elamanchili P, Kwon GS, Samuel J.
    J Pharm Pharm Sci; 2007 Oct 04; 10(2):217-30. PubMed ID: 17706180
    [Abstract] [Full Text] [Related]

  • 33. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.
    Schwendeman SP, Costantino HR, Gupta RK, Tobio M, Chang AC, Alonso MJ, Siber GR, Langer R.
    Dev Biol Stand; 1996 Oct 04; 87():293-306. PubMed ID: 8854030
    [Abstract] [Full Text] [Related]

  • 34. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
    Pettit DK, Lawter JR, Huang WJ, Pankey SC, Nightlinger NS, Lynch DH, Schuh JA, Morrissey PJ, Gombotz WR.
    Pharm Res; 1997 Oct 04; 14(10):1422-30. PubMed ID: 9358556
    [Abstract] [Full Text] [Related]

  • 35. Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres.
    Xing DK, McLellan K, Corbel MJ, Sesardic D.
    Biologicals; 1996 Mar 04; 24(1):57-65. PubMed ID: 8733602
    [Abstract] [Full Text] [Related]

  • 36. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres.
    Prior S, Gander B, Blarer N, Merkle HP, Subirá ML, Irache JM, Gamazo C.
    Eur J Pharm Sci; 2002 Mar 04; 15(2):197-207. PubMed ID: 11849917
    [Abstract] [Full Text] [Related]

  • 37. New strategies for the microencapsulation of tetanus vaccine.
    Schwendeman SP, Tobío M, Joworowicz M, Alonso MJ, Langer R.
    J Microencapsul; 1998 Mar 04; 15(3):299-318. PubMed ID: 9608394
    [Abstract] [Full Text] [Related]

  • 38. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
    Lavelle EC, Yeh MK, Coombes AG, Davis SS.
    Vaccine; 1999 Feb 12; 17(6):512-29. PubMed ID: 10075157
    [Abstract] [Full Text] [Related]

  • 39. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres.
    Ravivarapu HB, Burton K, DeLuca PP.
    Eur J Pharm Biopharm; 2000 Sep 12; 50(2):263-70. PubMed ID: 10962237
    [Abstract] [Full Text] [Related]

  • 40. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.
    Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP.
    Pharm Res; 1999 Apr 12; 16(4):509-13. PubMed ID: 10227704
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.